87 related articles for article (PubMed ID: 21656238)
1. Establishment of secondary iron overloaded mouse model: evaluation of cardiac function and analysis according to iron concentration.
Moon SN; Han JW; Hwang HS; Kim MJ; Lee SJ; Lee JY; Oh CK; Jeong DC
Pediatr Cardiol; 2011 Oct; 32(7):947-52. PubMed ID: 21656238
[TBL] [Abstract][Full Text] [Related]
2. d-Propranolol protects against oxidative stress and progressive cardiac dysfunction in iron overloaded rats.
Kramer JH; Spurney CF; Iantorno M; Tziros C; Chmielinska JJ; Mak IT; Weglicki WB
Can J Physiol Pharmacol; 2012 Sep; 90(9):1257-68. PubMed ID: 22913465
[TBL] [Abstract][Full Text] [Related]
3. In vivo calibration of the T2* cardiovascular magnetic resonance method at 1.5 T for estimation of cardiac iron in a minipig model of transfusional iron overload.
Jensen PD; Nielsen AH; Simonsen CW; Baandrup UT; Jensen SE; Bøgsted M; Magnusdottir SO; Jensen ABH; Kjaergaard B
J Cardiovasc Magn Reson; 2021 Mar; 23(1):27. PubMed ID: 33691716
[TBL] [Abstract][Full Text] [Related]
4. Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.
Wood JC; Otto-Duessel M; Aguilar M; Nick H; Nelson MD; Coates TD; Pollack H; Moats R
Circulation; 2005 Jul; 112(4):535-43. PubMed ID: 16027257
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis inhibitor improves cardiac function more effectively than inhibitors of apoptosis and necroptosis through cardiac mitochondrial protection in rats with iron-overloaded cardiomyopathy.
Kumfu S; Sripetchwandee J; Thonusin C; Sumneang N; Maneechote C; Arunsak B; Chunchai T; Oo TT; Kongkaew A; Chattipakorn SC; Chattipakorn N
Toxicol Appl Pharmacol; 2023 Nov; 479():116727. PubMed ID: 37863361
[TBL] [Abstract][Full Text] [Related]
6. Prooxidant mechanisms in iron overload cardiomyopathy.
Cheng CF; Lian WS
Biomed Res Int; 2013; 2013():740573. PubMed ID: 24350287
[TBL] [Abstract][Full Text] [Related]
7. Iron overload cardiomyopathy: better understanding of an increasing disorder.
Gujja P; Rosing DR; Tripodi DJ; Shizukuda Y
J Am Coll Cardiol; 2010 Sep; 56(13):1001-12. PubMed ID: 20846597
[TBL] [Abstract][Full Text] [Related]
8. More Than Meets the Eye: Defining the Prevalence, Pathophysiology, and Approach to Myocardial Iron Overload.
Truby LK; Michelis K; Grodin JL
Am J Cardiol; 2024 May; 219():38-43. PubMed ID: 38461925
[No Abstract] [Full Text] [Related]
9. Intestinal iron absorption studies in mouse models of iron-overload.
Raja KB; Simpson RJ; Peters TJ
Br J Haematol; 1994 Jan; 86(1):156-62. PubMed ID: 8011525
[TBL] [Abstract][Full Text] [Related]
10. Differences in activation of mouse hepcidin by dietary iron and parenterally administered iron dextran: compartmentalization is critical for iron sensing.
Daba A; Gkouvatsos K; Sebastiani G; Pantopoulos K
J Mol Med (Berl); 2013 Jan; 91(1):95-102. PubMed ID: 22847740
[TBL] [Abstract][Full Text] [Related]
11. Experimental animal model to study iron overload and iron chelation and review of other such models.
Italia K; Colah R; Ghosh K
Blood Cells Mol Dis; 2015 Oct; 55(3):194-9. PubMed ID: 26227843
[TBL] [Abstract][Full Text] [Related]
12. The C57BL/6 genetic background confers cardioprotection in iron-overloaded mice.
Musumeci M; Maccari S; Sestili P; Massimi A; Corritore E; Marano G; Catalano L
Blood Transfus; 2013 Jan; 11(1):88-93. PubMed ID: 22790263
[TBL] [Abstract][Full Text] [Related]
13. [Establishment of an mouse model of iron-overload and its impact on bone marrow hematopoiesis].
Chai X; Zhao MF; Li DG; Meng JX; Lu WY; Mu J; Meng AM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Oct; 35(5):547-52. PubMed ID: 24183045
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin knockout mice fed with iron-rich diet develop chronic liver injury and liver fibrosis due to lysosomal iron overload.
Lunova M; Goehring C; Kuscuoglu D; Mueller K; Chen Y; Walther P; Deschemin JC; Vaulont S; Haybaeck J; Lackner C; Trautwein C; Strnad P
J Hepatol; 2014 Sep; 61(3):633-41. PubMed ID: 24816174
[TBL] [Abstract][Full Text] [Related]
15. Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis.
Ramos E; Ruchala P; Goodnough JB; Kautz L; Preza GC; Nemeth E; Ganz T
Blood; 2012 Nov; 120(18):3829-36. PubMed ID: 22990014
[TBL] [Abstract][Full Text] [Related]
16. An animal model of iron overload and its application to study hepatic ferritin iron mobilization by chelators.
Longueville A; Crichton RR
Biochem Pharmacol; 1986 Nov; 35(21):3669-78. PubMed ID: 3778498
[TBL] [Abstract][Full Text] [Related]
17. Minimal effect of conditional ferroportin KO in the neural retina implicates ferrous iron in retinal iron overload and degeneration.
Liu Y; Baumann B; Song Y; Zhang K; Sterling JK; Lakhal-Littleton S; Kozmik Z; Su G; Dunaief JL
Exp Eye Res; 2022 May; 218():108988. PubMed ID: 35202704
[TBL] [Abstract][Full Text] [Related]
18. A facile colorimetric method for the quantification of labile iron pool and total iron in cells and tissue specimens.
Abbasi U; Abbina S; Gill A; Bhagat V; Kizhakkedathu JN
Sci Rep; 2021 Mar; 11(1):6008. PubMed ID: 33727584
[TBL] [Abstract][Full Text] [Related]
19. Iron Accumulates in Retinal Vascular Endothelial Cells But Has Minimal Retinal Penetration After IP Iron Dextran Injection in Mice.
Shu W; Baumann BH; Song Y; Liu Y; Wu X; Dunaief JL
Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4378-4387. PubMed ID: 31634395
[TBL] [Abstract][Full Text] [Related]
20. Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update.
Gordan R; Wongjaikam S; Gwathmey JK; Chattipakorn N; Chattipakorn SC; Xie LH
Heart Fail Rev; 2018 Sep; 23(5):801-816. PubMed ID: 29675595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
